Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Clinical trial NCT00080886 · COMPLETED
Trial details
- NCT number
- NCT00080886
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-08
- Primary completion
- 2005-11-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.